BIOMX INC (PHGE)

Company Profile

Biomx Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Gaithersburg, Maryland and currently employs 58 full-time employees. The company went IPO on 2018-12-18. BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The firm is focused on developing both natural and engineered phage therapies. The company develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The firm discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Company Info

BIOMX INC

708 Quince Orchard Rd, Suite 205

Gaithersburg MARYLAND 7414002

P: 18449720500

CEO: Jonathan Solomon

Employees: 65

Website: https://www.biomx.com/